Market expansion Recent US office expansion and headcount growth indicate increased commercial activity and regional sales capacity, presenting a sales opportunity to upsell additional micro-ultrasound systems, service contracts, and training packages to new territories and growing teams.

Financing runway A $10M financing round in 2026 and continued investor backing suggest strong capital availability for purchasing decisions, enabling proactive engagement around financing options, leasing, and phased deployment of ExactVu/FusionVu systems to larger urology practices and networks.

Regulatory trust CE Mark, FDA 510(k), and Health Canada approvals reinforce credibility for selling into multiple major markets and communicating regulatory readiness to prospects, supporting proposals for broader adoption in clinics seeking compliant, high-resolution micro-ultrasound guidance.

Workflow integration Platform notes emphasize ease of use and seamless integration into current urological workflows, offering opportunities to position bundled solutions that include training, software licenses, and integration with existing EMR/SaaS tools to reduce adoption friction.

Accountable leadership Leadership onboarding of US commercial team and growth in sales presence signals a focus on enterprise accounts and multi-site clinics; target hospital networks and academic centers with multi-venue procurement needs, highlighting case studies, ROI, and referral potential.